YOKNEAM, Israel , Nov. 5, 2025 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD) ("InMode") , a leading global provider of innovative medical technologies, today announced its consolidated financial...
IRVINE, Calif. , Nov. 3, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, has appointed Michael Dennison, most recently Vice President...
YOKNEAM, Israel , Oct. 30, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation in the following investor...
Barclays analyst Matt Miksic reiterated a Buy rating on InMode yesterday and set a price target of $21.00. The company’s shares closed yesterday at $15.89.Elevate Your Investing Strategy: Take advantage...
In a report released today, Michael Matson from Needham maintained a Hold rating on InMode. The company’s shares closed yesterday at $15.89.Elevate Your Investing Strategy: Take advantage of TipRanks...
Conference call to be held on Wednesday, November 5, 2025, at 8:30 a.m. Eastern Time
Believes the Board Should Approve and Execute a 10% Buyback in Q4 2025 and Another 10% Buyback in Q1 2026
YOKNEAM, Israel , Sept. 2, 2025 /PRNewswire/ --Â InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Yair Malca ...
YOKNEAM, Israel , Aug. 5, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) , a leading global provider of innovative medical technologies, today announced the participation in the...